Company news
TCGX Acquisition Corp. news
Latest news releases, newest first.
TriGemX Bio Appoints Daniel Lynch as Chairman of the TriGemX Bio Board of Directors
November 9, 2026
TriGemX Bio and TCGX Acquisition Corp. Announce Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Business Combination
November 2, 2026
TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, a Potential First-in-Class Treatment for Migraine
October 19, 2026
TCGX Acquisition Corp. II Announces Pricing of $100,000,000 Initial Public Offering
October 15, 2026
TCGX Acquisition Corp. Announces Completion of its Initial Public Offering
August 6, 2026
Decks
- SPAC Merger (October 2026)
SPAC merger · 31 slides · Oct 19, 2026